|
Volumn 24, Issue 10, 2001, Pages 1097-1101
|
Shark cartilage as source of antiangiogenic compounds: From basic to clinical research
|
Author keywords
Angiogenesis; Cancer; Shark cartilage
|
Indexed keywords
AE 941;
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
TISSUE EXTRACT;
U 995;
UNCLASSIFIED DRUG;
ANGIOGENESIS;
ANIMAL MODEL;
CANCER PATIENT;
CANCER THERAPY;
CARTILAGE;
CATTLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG SCREENING;
EXTRACT;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
IN VIVO STUDY;
MEDICAL LITERATURE;
MEDICAL RESEARCH;
MOUSE;
NONHUMAN;
POWDER;
REVIEW;
SHARK;
TREATMENT OUTCOME;
TUMOR GROWTH;
VASCULARIZATION;
ANGIOGENESIS INHIBITORS;
ANIMALS;
CARTILAGE;
HUMANS;
SHARKS;
|
EID: 0035172913
PISSN: 09186158
EISSN: None
Source Type: Journal
DOI: 10.1248/bpb.24.1097 Document Type: Review |
Times cited : (35)
|
References (38)
|